Cerulean Pharma reported $30.88M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US USD 2.85M 4.2M
Agile Therapeutics AGRX:US USD 6.26M 2.84M
Arrowhead Research ARWR:US USD 398.52M 55.41M
Bayer BAYN:GR EUR 41.27B 3.25B
Brainstorm Cell Therapeutics BCLI:US USD 1.39M 6.46M
Immunogen IMGN:US USD 178.01M 71.82M
Macrogenics MGNX:US USD 122.96M 19.52M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Perrigo Ordinary Shares PRGO:US USD 4.6B 247.1M
Seattle Genetics SGEN:US USD 2.82B 111M
YTE INCY:US USD 4.23B 141.59M